In this regard, Calabrese found that total 5-hmC levels are reduced by the downregulation of TET2 enzyme expression in PBMCs from MS untreated patients [28], suggesting that pathogenesis per se affects blood 5-hmC levels. Here, TET2 is linked to myeloid sarcoma.